Roellig C, Steffen B, Schliemann C, Mikesch JH, Alakel N, Herbst R, Haenel M, Noppeney R, Hanoun M, Kaufmann M, Racil Z, Schaefer-Eckart K, Sauer T, Neubauer A, Baldus CD, Mertova J, Jost E, Niemann D, Novak J, Krause S, Scholl S, Hochhaus A, Held G, Szotkowski T, Schmid C, Rank A, Fransecky L, Kramer M, Fiebig F, Haake A, Stoelzel F, Schetelig J, Middeke JM, Platzbecker U, Thiede C, Mueller-Tidow C, Berdel WE, Serve H, Ehninger G, Mayer J, Bornhaeuser M (2022)
Publication Type: Conference contribution
Publication year: 2022
Publisher: AMER SOC HEMATOLOGY
City/Town: WASHINGTON
Conference Proceedings Title: BLOOD
Event location: New Orleans, LA
DOI: 10.1182/blood-2022-157126
APA:
Roellig, C., Steffen, B., Schliemann, C., Mikesch, J.-H., Alakel, N., Herbst, R.,... Bornhaeuser, M. (2022). Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial. In BLOOD. New Orleans, LA, US: WASHINGTON: AMER SOC HEMATOLOGY.
MLA:
Roellig, Christoph, et al. "Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial." Proceedings of the 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA WASHINGTON: AMER SOC HEMATOLOGY, 2022.
BibTeX: Download